CSL Behring Solicits Proposals for LEAD Grants to Support Patient Advocacy Efforts

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--CSL Behring, a global leader in the plasma-protein biotherapeutics industry, is calling for grant requests through its Local Empowerment for Advocacy Development (LEAD) program. The LEAD program awards funds to United States patient organizations that assist people with rare diseases in advocating for continued access to health care and life-saving plasma protein therapies.